STAT April 8, 2024
Roy Perlis

Anyone can now walk into a pharmacy in the United States and buy oral contraceptives over the counter without a prescription, thanks to the FDA’s approval of norgestrel (Opill). This change reflects the drug’s safety and the public health imperative to ensure wider access to birth control. But another safe class of medicine that addresses a massive public health need remains unavailable except by prescription: the antidepressants known as selective serotonin reuptake inhibitors (SSRIs).

These medications, which have been used in the U.S. for three decades, have repeatedly been shown to be safe and effective for treating major depression and anxiety disorders.

The need for accessible depression treatment has never been greater. Multiple national surveys, including one I help lead,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Pharma Pulse 4/29/24: Examining Drug Shortages Before and During the COVID-19 Pandemic, Saudi Arabia Spends Big to Become an AI Superpower & more
STAT+: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Ono swoops on Deciphera in $2.4 billion takeover

Share This Article